2024 Q2 Form 10-Q Financial Statement

#000159169824000100 Filed on May 03, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $357.3M $401.3M
YoY Change 15.83% 18.07%
Cost Of Revenue $116.9M $116.0M
YoY Change 20.86% 21.18%
Gross Profit $240.4M $285.3M
YoY Change 13.54% 16.86%
Gross Profit Margin 67.29% 71.1%
Selling, General & Admin $133.3M $135.6M
YoY Change 9.4% 11.68%
% of Gross Profit 55.45% 47.54%
Research & Development $44.20M $43.39M
YoY Change 9.01% 2.51%
% of Gross Profit 18.39% 15.21%
Depreciation & Amortization $20.65M $5.220M
YoY Change 26.01% 12.67%
% of Gross Profit 8.59% 1.83%
Operating Expenses $177.5M $179.0M
YoY Change 9.3% 9.31%
Operating Profit $62.91M $106.3M
YoY Change 27.47% 32.24%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $5.573M $4.324M
YoY Change 112.95% 279.63%
Pretax Income $68.48M $110.6M
YoY Change 31.77% 35.69%
Income Tax $19.66M $25.30M
% Of Pretax Income 28.71% 22.87%
Net Earnings $48.82M $85.31M
YoY Change 31.04% 48.07%
Net Earnings / Revenue 13.66% 21.26%
Basic Earnings Per Share $1.51
Diluted Earnings Per Share $0.86 $1.50
COMMON SHARES
Basic Shares Outstanding 56.43M shares 56.33M shares
Diluted Shares Outstanding 57.05M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $401.8M $492.7M
YoY Change 39.15% 110.83%
Cash & Equivalents $401.8M $492.7M
Short-Term Investments
Other Short-Term Assets $2.992B $3.628B
YoY Change 12.62% 12.27%
Inventory
Prepaid Expenses
Receivables $33.00M $33.71M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.524B $4.247B
YoY Change 15.62% 19.08%
LONG-TERM ASSETS
Property, Plant & Equipment $60.64M $60.77M
YoY Change -43.92% 1.18%
Goodwill $108.9M $108.5M
YoY Change 6.74% 6.34%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.89M $26.56M
YoY Change 12.25% 8.25%
Total Long-Term Assets $721.0M $706.5M
YoY Change 11.39% 12.59%
TOTAL ASSETS
Total Short-Term Assets $3.524B $4.247B
Total Long-Term Assets $721.0M $706.5M
Total Assets $4.245B $4.953B
YoY Change 14.88% 18.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.638M $5.181M
YoY Change 40.39% -34.98%
Accrued Expenses $158.3M $170.6M
YoY Change 33.32% 18.22%
Deferred Revenue $25.95M $27.54M
YoY Change 5.75% 17.33%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.117B $3.765B
YoY Change 12.35% 12.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.398M $6.008M
YoY Change -90.34% 56.87%
Total Long-Term Liabilities $6.398M $6.008M
YoY Change -90.34% 56.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.117B $3.765B
Total Long-Term Liabilities $6.398M $6.008M
Total Liabilities $3.212B $3.854B
YoY Change 12.6% 12.52%
SHAREHOLDERS EQUITY
Retained Earnings $673.5M $624.6M
YoY Change 44.3% 45.46%
Common Stock $56.00K $56.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.033B $1.099B
YoY Change
Total Liabilities & Shareholders Equity $4.245B $4.953B
YoY Change 14.88% 18.11%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $48.82M $85.31M
YoY Change 31.04% 48.07%
Depreciation, Depletion And Amortization $20.65M $5.220M
YoY Change 26.01% 12.67%
Cash From Operating Activities $79.93M $167.5M
YoY Change 4.33% 31.55%
INVESTING ACTIVITIES
Capital Expenditures $22.55M $20.58M
YoY Change -17.75% 57.17%
Acquisitions
YoY Change
Other Investing Activities -$2.929M $6.354M
YoY Change -102.76% -104.14%
Cash From Investing Activities -$25.48M -$14.22M
YoY Change -132.42% -91.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -785.9M 297.6M
YoY Change 37.22% 125.62%
NET CHANGE
Cash From Operating Activities 79.93M 167.5M
Cash From Investing Activities -25.48M -14.22M
Cash From Financing Activities -785.9M 297.6M
Net Change In Cash -731.5M 450.9M
YoY Change 75.19% 386.51%
FREE CASH FLOW
Cash From Operating Activities $79.93M $167.5M
Capital Expenditures $22.55M $20.58M
Free Cash Flow $57.38M $147.0M
YoY Change 16.63% 28.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
179009000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
80377000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62471000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48888000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3731000 usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6008000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11820000 usd
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
33534000 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
155000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
155000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55912000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55912000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56427000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56427000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
56000 usd
CY2023Q2 us-gaap Investments
Investments
2910182000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2852817000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
3853623000 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
56000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
380632000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
466690000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
624637000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4515000 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-693000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
842863000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3695680000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4953037000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
314170000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
366840000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
50135000 usd
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
88287000 usd
CY2023Q1 us-gaap Revenues
Revenues
339857000 usd
CY2024Q1 us-gaap Revenues
Revenues
401281000 usd
us-gaap Revenues
Revenues
866145000 usd
us-gaap Revenues
Revenues
1045228000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
95714000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
115983000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
270333000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
324849000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
244143000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
285298000 usd
us-gaap Gross Profit
GrossProfit
595812000 usd
us-gaap Gross Profit
GrossProfit
720379000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
74064000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
86760000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
220821000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
246940000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42323000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43386000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
123445000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
134130000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47379000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48863000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
145872000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
142125000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
163766000 usd
us-gaap Operating Expenses
OperatingExpenses
490138000 usd
us-gaap Operating Expenses
OperatingExpenses
523195000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
105674000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
197184000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1139000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4324000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
971000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11349000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
81516000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
110613000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
106645000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
208533000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23900000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25299000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3077000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50586000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
85314000 usd
us-gaap Net Income Loss
NetIncomeLoss
103568000 usd
us-gaap Net Income Loss
NetIncomeLoss
157947000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1919000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1227000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
63000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3822000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
59535000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
84087000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
103631000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
161769000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.83
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55788000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56369000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56555000 shares
CY2023Q1 pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
613463000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
842863000 usd
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
475414000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1099414000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
106289000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
57616000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.81
CY2023Q1 pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
4993000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
986773000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39221000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1549000 usd
CY2024Q1 pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
CY2024Q1 pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
12216000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1227000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
85314000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1099414000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
127373000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3129000 usd
pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8450000 usd
pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
87300000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
63000 usd
us-gaap Net Income Loss
NetIncomeLoss
103568000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
768746000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
131305000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2033000 usd
pcty Stock Issued During Period Value Equity Award Vesting
StockIssuedDuringPeriodValueEquityAwardVesting
0 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
9534000 usd
pcty Net Settlement For Taxes Andor Exercise Price Related To Equity Awards
NetSettlementForTaxesAndorExercisePriceRelatedToEquityAwards
48090000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3822000 usd
us-gaap Net Income Loss
NetIncomeLoss
157947000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1099414000 usd
us-gaap Profit Loss
ProfitLoss
103568000 usd
us-gaap Profit Loss
ProfitLoss
157947000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
116002000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
117165000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
44481000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55779000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1308000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18543000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
864000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
713000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3602000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
3688000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1567000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3111000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12548000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9913000 usd
pcty Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
62929000 usd
pcty Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
50807000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2031000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2191000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
10000 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-554000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
206107000 usd
pcty Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
15355000 usd
pcty Increase Decrease In Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities
24856000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
304739000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
557403000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
231672000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
298113000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
222712000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
30726000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
44501000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8769000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11701000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12031000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-33000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-783000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-298752000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76410000 usd
pcty Increase Decrease In Client Funds Obligation
IncreaseDecreaseInClientFundsObligation
785361000 usd
pcty Increase Decrease In Client Funds Obligation
IncreaseDecreaseInClientFundsObligation
-964082000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
8450000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
9534000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
84174000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
46057000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-873000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-35000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-861958000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
927524000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-954603000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1155853000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3793453000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2421312000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2838850000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3577165000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3115000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2777000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
117000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
378000 usd
us-gaap Interest Paid Net
InterestPaidNet
372000 usd
CY2023Q1 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2605158000 usd
CY2024Q1 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
3084470000 usd
CY2023Q1 pcty Cash Cash Equivalents And Funds Held For Clients Cash And Cash Equivalent
CashCashEquivalentsAndFundsHeldForClientsCashAndCashEquivalent
2838850000 usd
CY2024Q1 pcty Cash Cash Equivalents And Funds Held For Clients Cash And Cash Equivalent
CashCashEquivalentsAndFundsHeldForClientsCashAndCashEquivalent
3577165000 usd
us-gaap Nature Of Operations
NatureOfOperations
<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) Organization and Description of Business</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>Paylocity Holding Corporation (the “Company”) is a cloud-based provider of human capital management and payroll software solutions that deliver a comprehensive platform for the modern workforce. Services are provided in a Software-as-a-Service (“SaaS”) delivery model. The Company’s comprehensive product suite delivers a unified platform that helps businesses attract and retain talent, build culture and connection with their employees, and streamline and automate HR and payroll processes.
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
366840000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
816010000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
956941000 usd
pcty Period Of Term Arrangement
PeriodOfTermArrangement
P2Y
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
314170000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
19737000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26245000 usd
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
12233000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
22617000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10211000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10932000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
30445000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
33164000 usd
CY2023Q1 pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
8589000 usd
CY2024Q1 pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
11324000 usd
pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
21319000 usd
pcty Total Revenue Recognized From Both The Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothTheBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
29928000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21359000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
25853000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21359000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
25853000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P7Y
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
330870000 usd
CY2023Q1 pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
41190000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-18176000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
353884000 usd
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
404980000 usd
CY2024Q1 pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
43684000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-22821000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
425843000 usd
CY2022Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
288568000 usd
pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
116077000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-50761000 usd
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
353884000 usd
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
372331000 usd
pcty Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
118280000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-64768000 usd
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
425843000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
74270000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P24M
CY2023Q2 us-gaap Goodwill
Goodwill
102054000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
6473000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1620000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
713000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
525000 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1808000 usd
CY2023Q2 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
248738000 usd
CY2024Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
305763000 usd
CY2023Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
162611000 usd
CY2024Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
195082000 usd
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
86127000 usd
CY2024Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
110681000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
141955000 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
148612000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77886000 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
87839000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64069000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60773000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
4633000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
5220000 usd
us-gaap Depreciation
Depreciation
13666000 usd
us-gaap Depreciation
Depreciation
15449000 usd
CY2023Q2 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2024Q1 us-gaap Goodwill
Goodwill
108527000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68569000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
72769000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
34042000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
41901000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34527000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30868000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2770000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2798000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8311000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7859000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2577000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9728000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8109000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5733000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3869000 usd
CY2024Q1 pcty Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
852000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
30868000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
85019000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
95787000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7800000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8021000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24539000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27544000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
25929000 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39223000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
143287000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
170575000 usd
CY2023Q2 pcty Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
288767000 usd
CY2023Q2 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288767000 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents Amortized Cost
FundsHeldForClientsCashAndCashEquivalentsAmortizedCost
2132545000 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2132545000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
494741000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
45000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5916000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
488870000 usd
CY2023Q2 pcty Investments Amortized Cost
InvestmentsAmortizedCost
2916053000 usd
CY2023Q2 pcty Investments Accumulated Gross Unrealized Gain Before Tax
InvestmentsAccumulatedGrossUnrealizedGainBeforeTax
45000 usd
CY2023Q2 pcty Investments Accumulated Gross Unrealized Loss Before Tax
InvestmentsAccumulatedGrossUnrealizedLossBeforeTax
5916000 usd
CY2023Q2 us-gaap Investments
Investments
2910182000 usd
CY2024Q1 pcty Cash And Cash Equivalents Amortized Cost
CashAndCashEquivalentsAmortizedCost
492695000 usd
CY2024Q1 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2024Q1 pcty Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
492695000 usd
CY2024Q1 pcty Funds Held For Clients Cash And Cash Equivalents Amortized Cost
FundsHeldForClientsCashAndCashEquivalentsAmortizedCost
3084470000 usd
CY2024Q1 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Gain Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2024Q1 pcty Funds Held For Clients Cash And Cash Equivalents Accumulated Gross Unrealized Loss Before Tax
FundsHeldForClientsCashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
0 usd
CY2024Q1 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
3084470000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
507388000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1932000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2592000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
506728000 usd
CY2024Q1 pcty Investments Amortized Cost
InvestmentsAmortizedCost
4084553000 usd
CY2024Q1 pcty Investments Accumulated Gross Unrealized Gain Before Tax
InvestmentsAccumulatedGrossUnrealizedGainBeforeTax
1932000 usd
CY2024Q1 pcty Investments Accumulated Gross Unrealized Loss Before Tax
InvestmentsAccumulatedGrossUnrealizedLossBeforeTax
2592000 usd
CY2024Q1 us-gaap Investments
Investments
4083893000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288767000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
492695000 usd
CY2023Q2 us-gaap Funds Held For Clients
FundsHeldForClients
2621415000 usd
CY2024Q1 us-gaap Funds Held For Clients
FundsHeldForClients
3591198000 usd
CY2024Q1 us-gaap Investments
Investments
4083893000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2305000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
344035000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3611000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
104818000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
5916000 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
448853000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
860000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
186134000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
1732000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
112844000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2592000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
298978000 usd
CY2023Q1 pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
CY2024Q1 pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
pcty Credit Impairment Loss
CreditImpairmentLoss
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
195435000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
194520000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
130594000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
129364000 usd
CY2024Q1 pcty Available For Sale Securities Debt Maturities Two Years To Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesTwoYearsToThreeYearsAmortizedCost
57927000 usd
CY2024Q1 pcty Available For Sale Securities Debt Maturities Two Years To Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesTwoYearsToThreeYearsFairValue
58282000 usd
CY2024Q1 pcty Debt Securities Available For Sale Amortized Cost Maturity Allocated And Single Maturity Date After Year Three Through Five
DebtSecuritiesAvailableForSaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearThreeThroughFive
123432000 usd
CY2024Q1 pcty Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date After Year Three Through Five
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearThreeThroughFive
124562000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
507388000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
506728000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288767000 usd
CY2023Q2 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
2132545000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
488870000 usd
CY2023Q2 us-gaap Investments
Investments
2910182000 usd
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
492695000 usd
CY2024Q1 pcty Funds Held For Clients Cash And Cash Equivalents At Carrying Value
FundsHeldForClientsCashAndCashEquivalentsAtCarryingValue
3084470000 usd
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
506728000 usd
CY2024Q1 us-gaap Investments
Investments
4083893000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.77
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32638000 usd
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34952000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
116002000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
117165000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2888000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3470000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
8984000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
11435000 usd
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
161800000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.293
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
57616000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
85314000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
103568000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
157947000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55788000 shares
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56369000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55653000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56216000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
767000 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
679000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
907000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
759000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56555000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57048000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56560000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56975000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.86
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.81
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.50
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
45000 shares
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
588000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
28000 shares
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001591698-24-000100-index-headers.html Edgar Link pending
0001591698-24-000100-index.html Edgar Link pending
0001591698-24-000100.txt Edgar Link pending
0001591698-24-000100-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcty-20240331.htm Edgar Link pending
pcty-20240331.xsd Edgar Link pending
pcty-20240331x10qex311.htm Edgar Link pending
pcty-20240331x10qex312.htm Edgar Link pending
pcty-20240331x10qex313.htm Edgar Link pending
pcty-20240331x10qex321.htm Edgar Link pending
pcty-20240331x10qex322.htm Edgar Link pending
pcty-20240331x10qex323.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
pcty-20240331_cal.xml Edgar Link unprocessable
pcty-20240331_def.xml Edgar Link unprocessable
pcty-20240331_lab.xml Edgar Link unprocessable
pcty-20240331_pre.xml Edgar Link unprocessable
pcty-20240331_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable